These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 25931375

  • 1. Galactose supplementation enhance sialylation of recombinant Fc-fusion protein in CHO cell: an insight into the role of galactosylation in sialylation.
    Liu J, Wang J, Fan L, Chen X, Hu D, Deng X, Poon HF, Wang H, Liu X, Tan WS.
    World J Microbiol Biotechnol; 2015 Jul; 31(7):1147-56. PubMed ID: 25931375
    [Abstract] [Full Text] [Related]

  • 2. Metabolic control of recombinant monoclonal antibody N-glycosylation in GS-NS0 cells.
    Hills AE, Patel A, Boyd P, James DC.
    Biotechnol Bioeng; 2001 Oct 20; 75(2):239-51. PubMed ID: 11536148
    [Abstract] [Full Text] [Related]

  • 3. Sialyllactose supplementation enhances sialylation of Fc-fusion glycoprotein in recombinant Chinese hamster ovary cell culture.
    Lee HM, Kim TH, Park JH, Heo NY, Kim HS, Kim DE, Lee MK, Lee GM, You J, Kim YG.
    J Biotechnol; 2024 Sep 10; 392():180-189. PubMed ID: 39038661
    [Abstract] [Full Text] [Related]

  • 4. Understanding of decreased sialylation of Fc-fusion protein in hyperosmotic recombinant Chinese hamster ovary cell culture: N-glycosylation gene expression and N-linked glycan antennary profile.
    Lee JH, Jeong YR, Kim YG, Lee GM.
    Biotechnol Bioeng; 2017 Aug 10; 114(8):1721-1732. PubMed ID: 28266015
    [Abstract] [Full Text] [Related]

  • 5. Effect of Bcl-xL overexpression on sialylation of Fc-fusion protein in recombinant Chinese hamster ovary cell cultures.
    Lee JH, Kim YG, Lee GM.
    Biotechnol Prog; 2015 Aug 10; 31(4):1133-6. PubMed ID: 26018766
    [Abstract] [Full Text] [Related]

  • 6. Glycoengineering of therapeutic glycoproteins: in vitro galactosylation and sialylation of glycoproteins with terminal N-acetylglucosamine and galactose residues.
    Raju TS, Briggs JB, Chamow SM, Winkler ME, Jones AJ.
    Biochemistry; 2001 Jul 31; 40(30):8868-76. PubMed ID: 11467948
    [Abstract] [Full Text] [Related]

  • 7. Evaluating the impact of suramin additive on CHO cells producing Fc-fusion protein.
    Lim JH, Cha HM, Han HJ, Kim DI.
    Biotechnol Lett; 2019 Nov 31; 41(11):1255-1263. PubMed ID: 31541331
    [Abstract] [Full Text] [Related]

  • 8. Insights into the loss of protein sialylation in an fc-fusion protein-producing CHO cell bioprocess.
    Chen X, Liu X, Xiao Z, Liu J, Zhao L, Tan WS, Fan L.
    Appl Microbiol Biotechnol; 2019 Jun 31; 103(12):4753-4765. PubMed ID: 31049620
    [Abstract] [Full Text] [Related]

  • 9. Metabolic control of recombinant protein N-glycan processing in NS0 and CHO cells.
    Baker KN, Rendall MH, Hills AE, Hoare M, Freedman RB, James DC.
    Biotechnol Bioeng; 2001 May 05; 73(3):188-202. PubMed ID: 11257601
    [Abstract] [Full Text] [Related]

  • 10. Gene-expression profiles for five key glycosylation genes for galactose-fed CHO cells expressing recombinant IL-4/13 cytokine trap.
    Clark KJ, Griffiths J, Bailey KM, Harcum SW.
    Biotechnol Bioeng; 2005 Jun 05; 90(5):568-77. PubMed ID: 15818560
    [Abstract] [Full Text] [Related]

  • 11. Monitoring sialylation levels of Fc-fusion protein using size-exclusion chromatography as a process analytical technology tool.
    Liu J, Chen X, Fan L, Deng X, Fai Poon H, Tan WS, Liu X.
    Biotechnol Lett; 2015 Jul 05; 37(7):1371-7. PubMed ID: 25782436
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Engineering host cell lines to reduce terminal sialylation of secreted antibodies.
    Naso MF, Tam SH, Scallon BJ, Raju TS.
    MAbs; 2010 Jul 05; 2(5):519-27. PubMed ID: 20716959
    [Abstract] [Full Text] [Related]

  • 14. Impact of Fc N-glycan sialylation on IgG structure.
    Zhang Z, Shah B, Richardson J.
    MAbs; 2019 Jul 05; 11(8):1381-1390. PubMed ID: 31411531
    [Abstract] [Full Text] [Related]

  • 15. Sialylation enhancement of CTLA4-Ig fusion protein in Chinese hamster ovary cells by dexamethasone.
    Jing Y, Qian Y, Li ZJ.
    Biotechnol Bioeng; 2010 Oct 15; 107(3):488-96. PubMed ID: 20521303
    [Abstract] [Full Text] [Related]

  • 16. Advances in analytical methodologies to guide bioprocess engineering for bio-therapeutics.
    Saldova R, Kilcoyne M, Stöckmann H, Millán Martín S, Lewis AM, Tuite CM, Gerlach JQ, Le Berre M, Borys MC, Li ZJ, Abu-Absi NR, Leister K, Joshi L, Rudd PM.
    Methods; 2017 Mar 01; 116():63-83. PubMed ID: 27832969
    [Abstract] [Full Text] [Related]

  • 17. Ammonium alters N-glycan structures of recombinant TNFR-IgG: degradative versus biosynthetic mechanisms.
    Gawlitzek M, Ryll T, Lofgren J, Sliwkowski MB.
    Biotechnol Bioeng; 2000 Jun 20; 68(6):637-46. PubMed ID: 10799988
    [Abstract] [Full Text] [Related]

  • 18. Correlative N-glycan and charge variant analysis of cetuximab expressed in murine, chinese hamster and human expression systems.
    Trappe A, Füssl F, Millán-Martín S, Ronan R, Zaborowska I, Bones J.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Apr 01; 1194():123186. PubMed ID: 35240429
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The Effect of Culture Temperature on the Aggregation of Recombinant TNFR-Fc is Regulated by the PERK-eIF2a Pathway in CHO Cells.
    Wang K, Zhang T, Chen J, Liu C, Tang J, Xie Q.
    Protein Pept Lett; 2018 Apr 01; 25(6):570-579. PubMed ID: 29848262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.